Avidity
Nick Wilkening has a diverse work experience in the biotech industry. Nick currently works as a Senior Manager of Program & Alliance Management at Avidity Biosciences, Inc. starting from 2023. Prior to that, they worked at Heron Therapeutics, Inc. where they held various roles in program management, including Senior Manager from July 2022 to December 2022, Manager from July 2020 to June 2022, Senior Associate from July 2018 to June 2020, Associate from January 2018 to June 2018, and Pharmacovigilance Associate from January 2017 to December 2017. Before joining Heron Therapeutics, Inc., they worked at Ardea Biosciences as a Pharmacovigilance Project Assistant from October 2015 to December 2016 and as a Patent Intern from June 2015 to September 2015. In their roles, they gained expertise in program management, pharmacovigilance, and patent-related tasks.
Nick Wilkening attended UC San Diego from 2011 to 2015, where they obtained a Bachelor of Science (B.S.) degree in Bioengineering (Biotechnology). Nick also has an additional certification in Microsoft Project, although the institution, month, and year of obtaining the certification are not provided.
Avidity
2 followers
Avidity Biosciences is pioneering a new class of precision medicines – antibody-siRNA conjugates (ASC™) – to deliver nucleic acid therapeutics against genetic drivers of disease. Our ASCs have drug-like properties similar to antibodies and antibody-drug conjugates. Importantly, their unique siRNA-based “payloads” permit selective targeting of disease-associated mRNAs against virtually any target of interest.